People | September 21, 2023
Parexel appoints Gwyn Bebb to lead oncology clinical development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Pfizer is likely to show GSK significant competition
Subscribe To Our Newsletter & Stay Updated
